Pricing Log in Create free account

Purple Biotech Ltd. Sponsored ADR (PPBT) vs Trevena, Inc. (TRVN)

Purple Biotech Ltd. Sponsored ADR and Trevena, Inc. are both Biotechnology companies. Purple Biotech Ltd. Sponsored ADR and Trevena, Inc. are of similar size ($2.0M and $1.8M). Purple Biotech Ltd. Sponsored ADR has the higher net margin (0.00% vs −6,233.7%) and the lower return on invested capital (−290.3% vs 0.00%). Across the 13 metrics below, Trevena, Inc. leads on 7 and Purple Biotech Ltd. Sponsored ADR on 6.

Valuation

Metric PPBT TRVN Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.10 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.16 n/m 0.64
EV/Sales n/m 35.04 9.21
Earnings yield (4,315.08%) 0.00% (33.15%)
Free cash flow yield (643.44%) 0.00% (25.50%)

Profitability

Metric PPBT TRVN Biotechnology median
Gross margin 0.00% (190.29%) 65.16%
Operating margin 0.00% (5,879.85%) 0.00%
Net margin 0.00% (6,233.70%) 0.00%
Free cash flow margin 0.00% (4,961.72%) 0.00%
Return on equity (110.67%) 344.49% (56.36%)
Return on assets (100.91%) (105.83%) (48.04%)
Return on invested capital (290.25%) 0.00% 0.00%

Growth

Metric PPBT TRVN Biotechnology median
Revenue growth (TTM) — (82.97%) 6.02%
EPS growth (last fiscal year) (10.14%) 58.37% 30.26%
Revenue growth, 5-year CAGR — (11.43%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PPBT TRVN Biotechnology median
Debt to equity 0.00 (1.41) 0.00
Current ratio 3.70 2.42 4.72
Net debt to EBITDA 0.35 0.06 0.96

Dividend

Metric PPBT TRVN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PPBT TRVN Biotechnology median
Market cap 1.99m 1.81m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack